Regencell Bioscience Holdings Limited Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-06-30 | $102.28K 20-F · filed 2025-10-31 | |
| 2023-06-30 | $134.91K 20-F · filed 2025-10-31 | |
| 2022-06-30 | $164.00K 20-F · filed 2024-10-25 |